ENDRA Life Sciences Inc (NASDAQ: NDRA) is -99.74% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $139.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NDRA stock was last observed hovering at around $0.25 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.28, the stock is 10.98% and 3.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.22 million and changing 10.93% at the moment leaves the stock -98.42% off its SMA200. NDRA registered -99.39% loss for a year compared to 6-month loss of -98.29%. The firm has a 50-day simple moving average (SMA 50) of $0.27022 and a 200-day simple moving average (SMA200) of $17.665565.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 37.78% gain in the last 1 month and extending the period to 3 months gives it a -91.62%, and is -0.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.24% over the week and 23.31% over the month.
ENDRA Life Sciences Inc (NDRA) has around 21 employees, a market worth around $5.61M and $0.00M in sales. Distance from 52-week low is 53.80% and -99.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.20%).
The EPS is expected to grow by 85.97% this year.
ENDRA Life Sciences Inc (NDRA) Top Institutional Holders
15.0 institutions hold shares in ENDRA Life Sciences Inc (NDRA), with institutional investors hold 0.09% of the company’s shares. The shares outstanding are 18.14M, and float is at 18.14M with Short Float at 3.96%. Institutions hold 0.09% of the Float.
ENDRA Life Sciences Inc (NDRA) Insider Activity
The most recent transaction is an insider purchase by UBS Group AG, the company’s 10% Owner. SEC filings show that UBS Group AG bought 3,715 shares of the company’s common stock on Aug 27 ’24 at a price of $0.55 per share for a total of $2052.0. Following the purchase, the insider now owns 0.15 million shares.
